ArticleProceedings of the National Academy of Sciences of the United States of America2007

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.

Kunle Odunsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.